xx/xxxxxxxxxx. It is hereby construed that the tenderers have availed themselves of these general conditions, and have read and accepted in full and without reservation the conditions outlined therein, and are therefore waiving any standard terms and conditions which they may have. TENDER PREVIEW These general conditions will form an integral part of the contract that will be signed with the successful tenderer/s.
xx/xxxxxxxxxx. Xx xxx xxxxx xx xxx xxxxxxxxxxx xx employment by the Company without Cause, by the Executive for Good Reason, the Executive shall be under no obligation to seek other employment, or otherwise engage in mitigating activity, following the date of termination, and there shall be no offset against amounts due the Executive under this Agreement on account of any remuneration attributable to any subsequent employment that he may obtain.
xx/xxxxxxxxxx xxxx.xx. The Ministry recommends that all services keep a copy of the identity verification document of each child who is enrolled at our service.
xx/xxxxxxxxxx. 11.2 The provider should ensure they submit timely and accurate information including, but not limited to, headcount data and census data. Failure to do so may result in inaccurate or delayed funding. Late submissions will be charged at: Headcount Data £10 per child Census Data £50 per setting
xx/xxxxxxxxxx. In addition to complying with all relevant legislation and regulations, the Parties will adhere to a common set of overarching guidelines, policies and principles. These assist the DHW with decision-making for the health care system and provide the common ground needed for each Party to work successfully together to address mutual objectives within stipulated timeframes.
xx/xxxxxxxxxx. 33. The provider should be clear and transparent about the SEND support on offer at their setting and make information available about their offer to support parents to choose the right setting for their child with SEND. Slough Early Years Service expects early years settings to provide for all children and the Area SENDCo offers support to providers about matters relating to inclusion and provision for specific needs. A school’s SENDCo provide this service for their schools. Social mobility and disadvantage
xx/xxxxxxxxxx. Xxxx Xxxxxxxxx xxxxx xxxxx to the benefit of and be binding upon the parties hereto. This Agreement may not be assigned.
xx/xxxxxxxxxx. 9.2 We may vary these terms and conditions as well as vary any of the charges payable by you under this Agreement:
xx/xxxxxxxxxx xx.xx The electronic- procurement system shall be used to manage the following aspects of tendering process; • Issuing the tendering document • Issuing addendum if any ITT 2.2 The intended completion date is 30th October 2023 ITT 4.1 Maximum number of members in the Joint Venture (JV) shall be: N/A B. Contents of Tendering Document ITT 8.1 i. The tenderer will submit any request for clarification in writing at the address: NATIONAL LAND COMMISSION GROUND FLOOR, ACK GARDEN ANNEX 1ST NGONG AVENUE P.O BOX 44417-00100 NAIROBI. To reach NLC not later than Wednesday 29th September, 2021 NLC will shall publish its response at the website xxx.xxxxxxxxxxxxxx.xx.xx xxx.xxxxxxx.xx.xx ITT 8.2 The tenderer will submit any questions in writing, to reach the procuring entity not later than Wednesday 29th September, 2021 at 11:00 AM. ITT 9.1 A. Pre-arranged pre tender site visit shall not take place B. Pre-tender meeting shall take place at the following ITT Reference PARTICULARS OF APPENDIX TO INSTRUCTIONS TO TENDERS Date: N/A Time: N/A Place: N/A C. Preparation of Tenders
xx/xxxxxxxxxx. Therapeutic Use The aim of stimulant medication as part of a comprehensive treatment programme is to stabilise children with a behavioural syndrome characterised by symptoms which may include chronic history of short attention span, distractibility, emotional lability, impulsivity and moderate to severe hyperactivity. DEXAMFETAMINE Dexamfetamine is used in children with refractory ADHD who do not respond to Methylphenidate or Atomoxetine. Dosage and Administration Child 6-17 years: Initially 2.5 mg – 2-3 times daily, increased if necessary at weekly intervals by 5mg, usual max.1mg/kg daily, up to 20 mg daily (40 mg daily has been required in some children). Formulation Tablets may be halved. Contraindications Cardiovascular disease including moderate to severe hypertension, structural cardiac abnormalities, advanced arteriosclerosis, hyper-excitability or agitated states, hyperthyroidism, history of drug or alcohol abuse. Cautions Mild hypertension, anorexia, psychosis or bipolar disorder, monitor for aggression and hostility during initial treatment, history of epilepsy, tics and Tourette syndrome, monitor growth in children, susceptibility to angle-closure glaucoma, avoid abrupt withdrawal, acute porphyria. Side effects Common or very common side effects include; abdominal cramps; acidosis; aggression; alopecia; anhedonia; anorexia; anxiety; ataxia; cardiomyopathy; cardiovascular collapse; cerebral vasculitis; chest pain; confusion; depression; diarrhoea; dizziness; dry mouth; dysphoria; euphoria; growth restriction in children; headache; hyperactivity; hyperpyrexia; hyperreflexia; hypertension; hypotension; impaired concentration; irritability; ischaemic colitis; malaise; mydriasis; myocardial infarction; nausea; nervousness; neuroleptic malignant syndrome; obsessive-compulsive behaviour; palpitations; panic attack; paranoia; psychosis; rash; renal impairment; restlessness; rhabdomyolysis; seizures; sexual dysfunction; sleep disturbances; stroke; sweating; tachycardia; taste disturbance; Tourette syndrome (in predisposed individuals); tremor; urticaria; visual disturbances; weight loss.
